tiprankstipranks

Profit $$ - New Portfolio

07EE2F92

Profit $$
Individual Investor
Ranked #435,439 out of 736,444 TipRanks' Investors
Success Rate
33%
416 out of 1259
profitable transactions
Average Return
-10.61%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 10.24%
6-Month Return▲ 15.74%
12-Month Return▼ 20.87%
YTD Return▼ 2.00%
Total Return▼ 21.99%

Best Trade

Opened at
Closed at-
Gain▲ 680.49%

Bio

bottom, turnover, profit, no long-term investment

Performance

16.65%0-16.65%
▼ 6.45%
▼ 2.17%
▼ 11.48%
Oct 2023
▲ 9.22%
▲ 9.13%
▲ 2.34%
Nov 2023
▲ 5.14%
▲ 4.57%
▲ 16.65%
Dec 2023
▼ 1.87%
▲ 1.59%
▼ 9.36%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 9.17%
Feb 2024
▲ 5.05%
▲ 3.27%
▼ 0.93%
Mar 2024
▼ 12.40%
▼ 4.03%
▼ 8.17%
Apr 2024
▲ 6.81%
▲ 4.78%
▲ 8.86%
May 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 6.45%▼ 2.17%▼ 11.48%
▲ 9.22%▲ 9.13%▲ 2.34%
▲ 5.14%▲ 4.57%▲ 16.65%
▼ 1.87%▲ 1.59%▼ 9.36%
▲ 14.08%▲ 5.22%▲ 9.17%
▲ 5.05%▲ 3.27%▼ 0.93%
▼ 12.40%▼ 4.03%▼ 8.17%
▲ 6.81%▲ 4.78%▲ 8.86%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Rallye SA
▼ 59.22%
5
Close
Apr 22, 2024
Hopium S.A.
▼ 30.62%
6
Close
Apr 09, 2024
Immunicum AB
▲ 56.25%
8
Close
Apr 09, 2024
HelloFresh SE
▼ 49.92%
2
Close
Apr 09, 2024
Cara Therapeutics
▲ 8.96%
5
Close
Apr 08, 2024
Check-Cap
▲ 46.56%
4
Close
Apr 08, 2024
180 Life Sciences
▼ 65.11%
7
Close
Apr 08, 2024
TFF Pharmaceuticals
▼ 1.36%
8
Close
Apr 08, 2024
BigBearai Holdings
▲ 6.98%
6
Close
Apr 08, 2024
BioNano Genomics
▼ 15.96%
5
Close
Apr 08, 2024
Iris Energy
▲ 10.48%
5
Close
Apr 08, 2024
Inovio Pharmaceuticals
▲ 105.43%
2
Close
Apr 08, 2024
AMC Entertainment
▼ 65.78%
2
Close
Apr 08, 2024
Moleculin Biotech
▼ 13.78%
2
Close
Apr 08, 2024
Charles & Colvard
▼ 58.14%
3
Close
Apr 08, 2024
Companhia Brasileira de Distribuicao
▼ 39.88%
2
Close
Apr 08, 2024
SeaStar Medical Holding
▲ 112.78%
4
Close
Apr 08, 2024
Theratechnologies
▼ 37.80%
4
Close
Apr 08, 2024
Cormedix
▲ 22.05%
2
Close
Apr 08, 2024
Citius Pharmaceuticals
▲ 20.73%
2
Close
Apr 08, 2024